Emerging Evidence in the Treatment of Obesity


In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.

To watch the video series component of this episode, click here.

1:20 Obesity-associated metabolic disturbances

5:37 When to start medication for obesity

8:28 Metabolic pathways leading to weight gain

13:19 Long-term impact of weight fluctuations

16:07 GLP-1 agonists for weight loss

20:26 Insurance coverage for anti-obesity medications (AOMs)

24:50 Combining lifestyle changes with AOMs

26:27 ‘Super-responders’ to GLP-1 agonist therapies

30:51 Non-responders to GLP-1 agonist therapies

37:28 Comprehensive approach to weight management

Related Videos
© 2024 MJH Life Sciences

All rights reserved.